Achilles Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Achilles Therapeutics has a total shareholder equity of $103.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $122.7M and $19.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$86.05m |
| Equity | US$103.14m |
| Total liabilities | US$19.54m |
| Total assets | US$122.68m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 698's short term assets ($111.6M) exceed its short term liabilities ($18.5M).
Long Term Liabilities: 698's short term assets ($111.6M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: 698 is debt free.
Reducing Debt: 698 has no debt compared to 5 years ago when its debt to equity ratio was 0.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 698 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 698 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 17.1% each year.